AOK Niedersachsen Die Gesundheitskasse Tender

Contract notice: Conclusion of a non-exclusive discount agreement according to § 130a para. 8 sgb v on medicinal products with the active ingredient follitropin alfa (atc code: g03ga05). Conclusion of a non-exclusive discount agreement according to § 130a para. 8 sgb v for medicinal products with the active ingredient follitropin alfa (atc code: g03ga05) within the period from 05/01/2022 to 04/30/2024 with the possibility of concluding a contract at any time during the term ("open-house model"). the contractual partners are available at: https://www.aok-gesundheitspartner.de/nds/arzneimittel/rabatt/index_03504.htmlbl=ndsFor the active substance follitropin alfa (atc code: g03ga05) offers the aok lower saxony. the health insurance company offers discount contracts to all interested pharmaceutical companies for the period up to the entry into force of exclusive contracts as a result of a formal award procedure in accordance with the regulations of part 4 of the GWB, without a selection decision. the contracts are concluded as part of an "open-house model" and act as a bridge between the start of generic competition (patent expiry) and the awarding of exclusive contracts. the contracts offered are not exclusive; contracts with all market participants (pharmaceutical companies) are desired by the aok of lower saxony. in the open-house model, uniform conditions apply to all participants. contract content, conditions and access procedures are uniform - individual negotiations are not conducted as a matter of principle. the contract terms are a maximum of twenty-four months, the earliest start of the contract is 05/01/2022. All contracts end on April 30th, 2024 at the latest, regardless of the date of the respective contract conclusion. A membership or a contract can be concluded within the twenty-four-month period on the first of each month. there is a right of termination six weeks to the end of the month. the aok lower saxony. the health insurance company reserves the right to replace the non-exclusive open-house discount contracts with exclusive discount contracts during the contract period. with the entry into force of advertised, exclusive discount contracts, the open-house contracts are terminated in accordance with the contractual provisions, i. H. the open-house contracts end automatically. according to the experience of aok lower saxony, exclusive discount agreements generally come into force six to eight months after the publication of the corresponding tender notice in the supplement to the official gazette of the european union. the future contractual partners in the open-house model are asked to regularly inform themselves about these tender announcements in the supplement to the official gazette of the european union. interested pharmaceutical companies can request the contractual documents and the contractual conditions at the contact address given under i.1). active ingredient follitropin alfa (atc code: g03ga05) will be concluded for